Eyal Sheetrit is an accomplished healthcare and biotech executive with over 20 years of experience in R&D, strategic consulting, and venture creation. As Co-Founder and CEO of Eximore, he led the development of an innovative ophthalmic drug-device platform, secured $10M in funding, and advanced two clinical trials across global markets. Eyal brings deep expertise in translating complex technologies into market-ready solutions, building strategic partnerships, and navigating regulatory and clinical pathways. His background spans leadership roles in business development at Ethicon, R&D management at Omrix, and strategic consulting, with a strong focus on medical technologies and healthcare innovation.